Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
ACS Chemical Neuroscience
|
August 4, 2012
A simple method for quantifying functional selectivity and agonist bias
Terry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Nucleic Acids Research
|
August 15, 2002
The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
Sikandar G Khan, Vanessa Muniz-Medina, Tala Shahlavi, et al.
International Journal of Cancer
|
February 6, 2007
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
Raul Catena, Vanessa Muniz-Medina, Beatriz Moralejo, et al.
Human Molecular Genetics
|
December 10, 2003
Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk
Sikandar G Khan, Ahmet Metin, Engin Gozukara, et al.
Mabs
|
March 6, 2019
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Jason B White, Ryan Fleming, Luke Masterson, et al.
Journal of the American Heart Association
|
December 11, 2019
Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse Heart
Junhui Sun, Weidong Hao, Natasha Fillmore, et al.
Carcinogenesis
|
August 6, 2005
Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients
Sikandar G Khan, Kyu-Seon Oh, Tala Shahlavi, et al.
Molecular Cancer Therapeutics
|
May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
ACS Chemical Neuroscience
|
August 4, 2012
A simple method for quantifying functional selectivity and agonist bias
Terry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Nucleic Acids Research
|
August 15, 2002
The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
Sikandar G Khan, Vanessa Muniz-Medina, Tala Shahlavi, et al.
International Journal of Cancer
|
February 6, 2007
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
Raul Catena, Vanessa Muniz-Medina, Beatriz Moralejo, et al.
Human Molecular Genetics
|
December 10, 2003
Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk
Sikandar G Khan, Ahmet Metin, Engin Gozukara, et al.
Mabs
|
March 6, 2019
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Jason B White, Ryan Fleming, Luke Masterson, et al.
Journal of the American Heart Association
|
December 11, 2019
Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse Heart
Junhui Sun, Weidong Hao, Natasha Fillmore, et al.
Carcinogenesis
|
August 6, 2005
Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients
Sikandar G Khan, Kyu-Seon Oh, Tala Shahlavi, et al.
Molecular Cancer Therapeutics
|
May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Page
of 1